Product correctly added to cart.

discount label
ZL0454
View 3D

Biosynth logo

ZL0454

CAS: 2229042-77-5

Ref. 3D-EPD04277

10mgTo inquire
25mgTo inquire
50mgTo inquire
Estimated delivery in United States, on Tuesday 21 Jan 2025

Product Information

Name:
ZL0454
Description:

ZL0454 is a small molecule that inhibits the inflammatory response by blocking the interaction between Toll-like receptor 4 and its ligand, lipopolysaccharide. This drug has been shown to have therapeutic potential in chronic viral infections, such as HIV and hepatitis C virus, as well as in inflammatory bowel disease. ZL0454 has also been shown to inhibit coagulation factor activity and has been found to be effective against a variety of cancers including breast, lung, prostate, and colon cancer. ZL0454 binds to bromodomains on histone proteins which are involved in regulating gene expression. This binding prevents acetylation of histones leading to reduced transcriptional activation of genes regulated by these proteins.
ZL0454 also interacts with epithelial mesenchymal transition proteins that regulate cell adhesion and migration.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
374.5 g/mol
Formula:
C18H22N4O3S
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-EPD04277 ZL0454

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".